Ovo Biomanufacturing

Software platform that helps viral vaccine manufacturers manage defective interfering particles and improve production yields

Coventry, United KingdomFounded 2019ovobiomanufacturing.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-07

About Ovo Biomanufacturing

OVO Biomanufacturing provides a cloud-based software platform that analyses next-generation sequencing data to assess defective interfering particle populations and recommend growth conditions for producing working seed stocks.

The platform is designed for manufacturers of live attenuated and inactivated viral vaccines and vectors. Its initial target market is influenza vaccines, and it is intended to fit within existing manufacturing processes and parameters.

OVO Biomanufacturing Ltd was founded in 2019 and is registered in Coventry, United Kingdom.

Product: Cloud-based software that analyses sequencing data and recommends conditions to manage defective interfering particles in viral manufacturing.

Jobs at Ovo Biomanufacturing

No open positions listed right now.

More biotech & pharma companies

  • Oxford Medical Products

    Develops gastroretentive hydrogel technologies for weight management and drug delivery applications
    Witney, United KingdomBiotech & pharmaFounded 20163 open jobs
    New on Evolc
  • oxfordglobal.co.uk

    Life-science conferences, expert webinars and editorial interviews connecting R&D leaders across pharma, biotech and academia
    United KingdomBiotech & pharma
    New on Evolc
  • Oxsonics

    Clinical-stage drug delivery company developing SonoTran, an ultrasound platform that boosts anti-cancer drug penetration into solid tumours
    Oxford, United KingdomBiotech & pharmaFounded 2013
    New on Evolc
  • Particology

    Contract particle science and solid form services for pharma teams taking small-molecule drugs to formulated products
    Sandwich, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Pathios Therapeutics

    Develops GPR65-targeting cancer immunotherapies for patients with solid tumors
    Abingdon, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Pencil Biosciences

    Synthetic gene-editing technology for therapeutic development and cell-line engineering
    Macclesfield, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WixHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Monitoring

  • SentryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.